SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 220.77 |
| Enterprise Value ($M) | 185.70 |
| Book Value ($M) | 198.40 |
| Book Value / Share | 3.11 |
| Price / Book | 1.11 |
| NCAV ($M) | 192.63 |
| NCAV / Share | 3.02 |
| Price / NCAV | 1.15 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.32 |
| Return on Assets (ROA) | -0.68 |
| Return on Equity (ROE) | -0.79 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.10 |
| Current Ratio | 13.10 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 213.26 |
| Assets | 219.02 |
| Liabilities | 20.62 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| SCHEDULE 13G/A | Janus Henderson Group Plc | |||
| 13G/A | Verition Fund Management LLC | 0.90 | -78.87 | |
| 13G/A | Blue Owl Capital Holdings LP | 6.53 | 22.03 | |
| 13G | Goldman Sachs Group Inc | 7.00 | ||
| 13D/A | Flynn James E | 33.32 | 0.04 | |
| 13G | Ra Capital Management, L.p. | 9.50 | ||
| 13G/A | Perceptive Advisors Llc | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 62,941 | 232,273 | 27.10 | |
| 61,326 | 284,959 | 21.52 | |
| 76,697 | 299,457 | 25.61 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KYMR – Kymera Therapeutics, Inc. | LGND – Ligand Pharmaceuticals Incorporated |
| LNTH – Lantheus Holdings, Inc. | LXEO – Lexeo Therapeutics, Inc. |
| MDWD – MediWound Ltd. |
Financial data and stock pages provided by
Fintel.io